Device
Zotarolimus-eluting stent
Zotarolimus-eluting stent is a medical device with 6 clinical trials. Historical success rate of 80.0%.
Total Trials
6
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
80.0%
Based on 4 completed trials
Completion Rate
80%(4/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(17%)
Phase Distribution
Ph not_applicable
2
33%
Ph phase_4
2
33%
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution4 total trials
Phase 4Post-market surveillance
2(50.0%)
N/ANon-phased studies
2(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
80.0%
4 of 5 finished
Non-Completion Rate
20.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Completed(4)
Terminated(1)
Other(1)
Detailed Status
Completed4
Terminated1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
80.0%
Most Advanced
Phase 4
Trials by Phase
Phase 42 (50.0%)
N/A2 (50.0%)
Trials by Status
terminated117%
unknown117%
completed467%
Recent Activity
0 active trials
Showing 5 of 6
completed
Efficacy and Safety of ZotaRolimus-Eluting Coronary Stent System In Patients With Long Coronary Artery Disease
NCT04825886
terminatednot_applicable
BES, EES, and ZES-R in Real World Practice
NCT01397175
unknown
Late Stent Strut Apposition and Coverage After Drug-Eluting Stent Implantation by OCT in Patients With AMI
NCT02770651
completednot_applicable
Effect of Rotablator on Balloon Resistant Calcified Coronary Lesion
NCT01887704
completedphase_4
A New Strategy Regarding Discontinuation of Dual Antiplatelet
NCT01145079
Clinical Trials (6)
Showing 6 of 6 trials
NCT04825886
Efficacy and Safety of ZotaRolimus-Eluting Coronary Stent System In Patients With Long Coronary Artery Disease
NCT01397175Not Applicable
BES, EES, and ZES-R in Real World Practice
NCT02770651
Late Stent Strut Apposition and Coverage After Drug-Eluting Stent Implantation by OCT in Patients With AMI
NCT01887704Not Applicable
Effect of Rotablator on Balloon Resistant Calcified Coronary Lesion
NCT01145079Phase 4
A New Strategy Regarding Discontinuation of Dual Antiplatelet
NCT00332397Phase 4
The Efficacy of Three Different Limus Agent-Eluting Stents to Prevent Restenosis
All 6 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 6